PARENTERAL FORMULATION OF RASAGILINE
This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasa...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ERAN BLAUGRUND AVIVA GROSS ROM E. ELIAZ ADI MAYK CHERYL FITZER-ATTAS |
| description | This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
Esta solicitud proporciona un método para inhibir preferentemente oxidasa de monoamina A (MAOA) en el cerebro de un sujeto en relación con el intestino del sujeto, que comprende administrar parenteralmente al sujeto una formulación de liberación controlada que comprende una cantidad terapéuticamente efectiva de rasagilina o una sal farmacéuticamente aceptable del mismo. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2015002062A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2015002062A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2015002062A3</originalsourceid><addsrcrecordid>eNrjZFAJcAxy9QtxDXL0UXDzD_IN9XEM8fT3U_B3UwhyDHZ09_Tx9HPlYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoamBgZGBmZGjsZEKQIA0aojiw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PARENTERAL FORMULATION OF RASAGILINE</title><source>esp@cenet</source><creator>ERAN BLAUGRUND ; AVIVA GROSS ; ROM E. ELIAZ ; ADI MAYK ; CHERYL FITZER-ATTAS</creator><creatorcontrib>ERAN BLAUGRUND ; AVIVA GROSS ; ROM E. ELIAZ ; ADI MAYK ; CHERYL FITZER-ATTAS</creatorcontrib><description>This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
Esta solicitud proporciona un método para inhibir preferentemente oxidasa de monoamina A (MAOA) en el cerebro de un sujeto en relación con el intestino del sujeto, que comprende administrar parenteralmente al sujeto una formulación de liberación controlada que comprende una cantidad terapéuticamente efectiva de rasagilina o una sal farmacéuticamente aceptable del mismo.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150605&DB=EPODOC&CC=MX&NR=2015002062A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150605&DB=EPODOC&CC=MX&NR=2015002062A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ERAN BLAUGRUND</creatorcontrib><creatorcontrib>AVIVA GROSS</creatorcontrib><creatorcontrib>ROM E. ELIAZ</creatorcontrib><creatorcontrib>ADI MAYK</creatorcontrib><creatorcontrib>CHERYL FITZER-ATTAS</creatorcontrib><title>PARENTERAL FORMULATION OF RASAGILINE</title><description>This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
Esta solicitud proporciona un método para inhibir preferentemente oxidasa de monoamina A (MAOA) en el cerebro de un sujeto en relación con el intestino del sujeto, que comprende administrar parenteralmente al sujeto una formulación de liberación controlada que comprende una cantidad terapéuticamente efectiva de rasagilina o una sal farmacéuticamente aceptable del mismo.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAJcAxy9QtxDXL0UXDzD_IN9XEM8fT3U_B3UwhyDHZ09_Tx9HPlYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoamBgZGBmZGjsZEKQIA0aojiw</recordid><startdate>20150605</startdate><enddate>20150605</enddate><creator>ERAN BLAUGRUND</creator><creator>AVIVA GROSS</creator><creator>ROM E. ELIAZ</creator><creator>ADI MAYK</creator><creator>CHERYL FITZER-ATTAS</creator><scope>EVB</scope></search><sort><creationdate>20150605</creationdate><title>PARENTERAL FORMULATION OF RASAGILINE</title><author>ERAN BLAUGRUND ; AVIVA GROSS ; ROM E. ELIAZ ; ADI MAYK ; CHERYL FITZER-ATTAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2015002062A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ERAN BLAUGRUND</creatorcontrib><creatorcontrib>AVIVA GROSS</creatorcontrib><creatorcontrib>ROM E. ELIAZ</creatorcontrib><creatorcontrib>ADI MAYK</creatorcontrib><creatorcontrib>CHERYL FITZER-ATTAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ERAN BLAUGRUND</au><au>AVIVA GROSS</au><au>ROM E. ELIAZ</au><au>ADI MAYK</au><au>CHERYL FITZER-ATTAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PARENTERAL FORMULATION OF RASAGILINE</title><date>2015-06-05</date><risdate>2015</risdate><abstract>This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
Esta solicitud proporciona un método para inhibir preferentemente oxidasa de monoamina A (MAOA) en el cerebro de un sujeto en relación con el intestino del sujeto, que comprende administrar parenteralmente al sujeto una formulación de liberación controlada que comprende una cantidad terapéuticamente efectiva de rasagilina o una sal farmacéuticamente aceptable del mismo.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2015002062A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PARENTERAL FORMULATION OF RASAGILINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-07T03%3A52%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ERAN%20BLAUGRUND&rft.date=2015-06-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2015002062A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |